Impact of pharmacogenetics on variability in exposure to oral vinorelbine among pediatric patients: a model‐based population pharmacokinetic analysis

M Hamimed, P Leblond, A Dumont… - Cancer Chemotherapy …, 2022 - Springer
Purpose Better understanding of pharmacokinetics of oral vinorelbine (VNR) in children
would help predicting drug exposure and, beyond, clinical outcome. Here, we have …

Drug interactions and cytotoxic effects of paclitaxel in combination with carboplatin, epirubicin, gemcitabine or vinorelbine in breast cancer cell lines and tumor …

G Konecny, M Untch, D Slamon, M Beryt… - Breast cancer research …, 2001 - Springer
The purpose of this study was to analyze the drug interactions of paclitaxel (PTX) with
epirubicin (EPI), carboplatin (CBDCA), gemcitabine (GEM) and vinorelbine (VIN) in human …

Anti-vascular effects of vinflunine in the MAC 15A transplantable adenocarcinoma model

SE Holwell, BT Hill, MC Bibby - British journal of cancer, 2001 - nature.com
Anti-vascular effects of the novel Vinca alkaloid, vinflunine have been investigated in the
MAC 15A transplantable murine colon adenocarcinoma model and compared with those …

Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines

HA Hahm, VR Dunn, KA Butash, WL Deveraux… - Clinical cancer …, 2001 - AACR
Polyamines are essential for cell growth and differentiation. Structural polyamine analogues
have been shown to have antitumor activity in experimental models including breast cancer …

Pharmacological factors influencing anticancer drug selection in the elderly

V John, S Mashru, SM Lichtman - Drugs & aging, 2003 - Springer
Persons over the age of 65 years are the fastest growing segment of the US population. In
the next 30 years this segment will represent more than 20% of the population. Fifty percent …

Measurement of chemoresistance markers in patients with stage III non–small cell lung cancer: a novel approach for patient selection

KR Brooks, K To, MBM Joshi, DH Conlon… - The Annals of thoracic …, 2003 - Elsevier
Background The long-term survival of patients with stage III non–small cell lung cancer
treated with a combination of chemotherapy and radiation is 10% to 20%. Survival could …

Pharmacology of antineoplastic agents in older cancer patients.

SM Lichtman, JA Skirvin - Oncology (Williston Park, NY), 2000 - europepmc.org
The fastest growing segment of the US population is the group over the age of 65 years. In
the next 30 years, this group will comprise over 20% of the population. Because 60% of all …

In vitro synergistic effects of vinflunine, a novel fluorinated vinca alkaloid, in combination with other anticancer drugs

JM Barret, C Etiévant, BT Hill - Cancer chemotherapy and pharmacology, 2000 - Springer
Abstract Purpose: Vinflunine (20′-20′-difluoro-3′, 4′-dihydrovinorelbine), a novel
derivative of vinorelbine characterized by marked antitumour activity in vivo in a series of …

Pharmacology of antineoplastic agents in older cancer patients

SM Lichtman, JA Skirvin, S Vemulapalli - Critical reviews in oncology …, 2003 - Elsevier
Persons over the age of 65 years are the fastest growing segment of the United States
population. In the next 30 years it will comprise over 20% of the population. Fifty percent of …

Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study

ML Rothenberg, PY Liu, S Wilczynski, WA Nahhas… - Gynecologic …, 2004 - Elsevier
OBJECTIVES.: To assess the activity of vinorelbine in women with recurrent or resistant
epithelial ovarian cancer following treatment with platinum and paclitaxel in terms of survival …